Latest news

Insights

Top 10 Metrics Clinical Operations Leaders Should Track

Executive Summary Clinical operations leaders must balance trial speed, cost, quality, participant safety, and operational reliability. As studies become more...
Commercial

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Georgiamune, a Maryland-based biotechnology company focused on immunology, has licensed an experimental cancer treatment to Stemline Therapeutics, a subsidiary...
Clinical

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Following Lisraya’s first regulatory approval, Roivant and its subsidiary Priovant are seeking to expand the drug’s reach into additional...
Clinical

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

Bristol Myers Squibb (BMS) has reported positive results from two phase 3 trials of izalontamab brengitecan (iza-bren), a bispecific...
Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Insights

Real-Time Commercial Intelligence in Life Sciences

Executive Summary Pharmaceutical commercial teams are operating in markets where...
Insights

Top 10 AI Skills Every Life Sciences Leader Needs

Executive Summary Artificial intelligence is reshaping drug discovery, clinical development, manufacturing, regulatory operations, and Medical Affairs. As adoption expands, life...
Insights

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Executive Summary Digital therapeutics (DTx) are evolving beyond standalone software interventions toward more personalized, connected, and clinically integrated treatment experiences....
Clinical

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Disc Medicine has reported that its experimental drug bitopertin met all primary and secondary endpoints in a phase 3...
Commercial

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

AstraZeneca will pay insitro $40 million upfront to use...
Commercial

Merck to Acquire Silence Therapeutics for $1.3 Billion, Adding Experimental Blood Cancer Therapy

Merck KGaA, Darmstadt, Germany, has entered into a definitive...
Manufacturing

GSK promises to invest $800 million to expand Pennsylvania’s capacity to produce biologics

GSK will spend over $800 million developing an Innovation and Manufacturing facility in Pennsylvania. Filling the funds will help...
Insights

Top 10 Advances in Protein Engineering

Executive Summary Protein engineering is expanding the range of molecules scientists can design, optimize, and manufacture for pharmaceutical, biotechnology, industrial,...
Insights

Top 10 Supply Chain Innovations in Life Sciences

Executive Summary Life sciences supply chains are becoming more complex as pharmaceutical companies manage biologics, cell and gene therapies, temperature-sensitive...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Georgiamune, a Maryland-based biotechnology company focused on immunology, has...
Editorial Team -
Commercial

Merck KGaA and Skyhawk Therapeutics Sign RNA Drug Discovery Pact Worth Up to $2 Billion

A Landmark Collaboration in RNA Therapeutics Merck KGaA has entered...
Commercial

Medtronic to Acquire Scientia Vascular for $550 Million to Expand Stroke Care Device Portfolio

Medtronic announced plans to acquire U.S.-based Scientia Vascular in...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Commercial

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Georgiamune, a Maryland-based biotechnology company focused on immunology, has...
Clinical

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Following Lisraya’s first regulatory approval, Roivant and its subsidiary...
Clinical

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

Bristol Myers Squibb (BMS) has reported positive results from...
Clinical

BioNTech Reports Modest Benefit and Safety Concerns in Phase 3 Breast Cancer Trial

BioNTech and DualityBio have reported topline results from DYNASTY-Breast02,...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Metrics Clinical Operations Leaders Should Track

Executive Summary Clinical operations leaders must balance trial speed, cost,...
Editorial Team -
Clinical

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Following Lisraya’s first regulatory approval, Roivant and its subsidiary...
Editorial Team -